MTOR and acute lymphoblastic leukemia: High-throughput sequencing studies have further elucidated the T-ALL genetic landscape, highlighting the recurrent activation of oncogenic pathways, including IL-7R/JAK/STAT, PI3K/AKT/mTOR, and RAS/MAPK.